1. Home
  2. BBIO vs HII Comparison

BBIO vs HII Comparison

Compare BBIO & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$69.63

Market Cap

14.2B

Sector

Health Care

ML Signal

HOLD

Logo Huntington Ingalls Industries Inc.

HII

Huntington Ingalls Industries Inc.

HOLD

Current Price

$360.04

Market Cap

15.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBIO
HII
Founded
2015
1886
Country
United States
United States
Employees
N/A
44000
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.2B
15.5B
IPO Year
2019
2010

Fundamental Metrics

Financial Performance
Metric
BBIO
HII
Price
$69.63
$360.04
Analyst Decision
Strong Buy
Buy
Analyst Count
25
6
Target Price
$86.04
$411.33
AVG Volume (30 Days)
1.7M
351.1K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
1.54%
EPS Growth
N/A
10.24
EPS
N/A
15.39
Revenue
$502,076,000.00
$12,484,000,000.00
Revenue This Year
$89.45
$4.82
Revenue Next Year
$73.78
$6.28
P/E Ratio
N/A
$23.22
Revenue Growth
126.26
8.23
52 Week Low
$31.77
$215.28
52 Week High
$84.94
$460.00

Technical Indicators

Market Signals
Indicator
BBIO
HII
Relative Strength Index (RSI) 40.40 33.11
Support Level $61.95 $351.63
Resistance Level $78.96 $433.85
Average True Range (ATR) 4.00 11.53
MACD -0.72 -3.26
Stochastic Oscillator 2.54 14.75

Price Performance

Historical Comparison
BBIO
HII

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: